R
Rameshchandra
About Rameshchandra
Data last updated:
Rameshchandra is a Director at Nexnos Pharma Limited (since 2023) and Director at Remescan Healthcare Private Limited (since 2025). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹39.91 Cr; the largest is Nexnos Pharma Limited at ₹36.91 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 May 2023 | 2007 | ₹36.91 Cr (FY 2025) | Active | |
| Director | 07 Nov 2025 | 2023 | ₹3.00 Cr (FY 2024) | Active |
Board colleagues of Rameshchandra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Kumar Agrawal | 10142531 | Nexnos Pharma Limited | Director |
| Kamal Asnani | 01649198 | Nexnos Pharma Limited | Director |
| Rajesh Peswani | 09209394 | Nexnos Pharma Limited | Director |
| Vinod Asnani | 01649207 | Nexnos Pharma Limited | Director |
| Anudesh Goyal | 07717128 | Remescan Healthcare Private Limited | Non- Individual Subscriber |
| Naresh Kumar Hasija | 06975385 | Remescan Healthcare Private Limited | Individual Subscriber |
| Naresh Kumar Hasija | Remescan Healthcare Private Limited | Ceo | |
| Ritesh Ravindra Somalwar | 11325540 | Remescan Healthcare Private Limited | Director |
| Tanmayata Naithani | 10014403 | Remescan Healthcare Private Limited | Individual Subscriber |
| Wonju Hwangbo | 10397079 | Remescan Healthcare Private Limited | Non- Individual Subscriber |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rameshchandra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rameshchandra
Rameshchandra currently holds 2 directorships: Nexnos Pharma Limited (Director, since 03 May 2023, revenue ₹36.91 Cr (FY 2025)); Remescan Healthcare Private Limited (Director, since 07 Nov 2025, revenue ₹3.00 Cr (FY 2024)).
Rameshchandra was first appointed on 03 May 2023 as Director at Nexnos Pharma Limited. The most recent appointment on record is 07 Nov 2025 at Remescan Healthcare Private Limited.
The 2 current companies of Rameshchandra that report revenue have a combined latest revenue of ₹39.91 Cr: Nexnos Pharma Limited ₹36.91 Cr (FY 2025); Remescan Healthcare Private Limited ₹3.00 Cr (FY 2024).
The current boards of Rameshchandra's companies include Ashish Kumar Agrawal (Nexnos Pharma Limited), Kamal Asnani (Nexnos Pharma Limited), Rajesh Peswani (Nexnos Pharma Limited), Vinod Asnani (Nexnos Pharma Limited), Anudesh Goyal (Remescan Healthcare Private Limited), Naresh Kumar Hasija (Remescan Healthcare Private Limited), among others.